Patents

Patents

Patent BR 102017005783-6 (21st March 2017) - INSTITUTO BUTANTAN – Reference: Sculptin

Patent BR 102018008561-1 - Patente de Invenção (PI) - Processo e Kit para identificar entidades moleculares envolvidas na dor de osteoartrite.

Patent application: “Process and Kit for identifying molecular entities involved in osteoarthritis pain”. Innovation Patent, number BR102019008695-5, on 29/04/2019. Depositante: Instituto Butantan. Inventors: Yara Cury, Michelle Cristiane Bufalo, Sandra Coccuzzo Sampaio, Vanessa Olzon Zambelli, Luciene Maria Zanchetta, Ana Marisa Chudzinski-Tavassi, Maíra Estanislau Soares de Almeida

Patent Application: Use of Amblyomin-X for the preparation of a medicament to simultaneously activate multiple pathways leading to tumour death; Composition and Method for modulating Immunogenic Cell Death (ICD) response without IFN (alpha, beta and gamma) expression; Improved pharmaceutical composition comprising Amblyomin-X. Patent Number WO/2006/029492. Depositor: Instituto Butantan. Inventors: Ana Marisa Chudzinski Tavassi, Flavio Lichtenstein, Mauricio Barbugiani Goldfeder, Katia Luciano Pereira Morais, Jean Gabriel de Souza, Carlos DeOcesano Pereira, Roger Chammas

Patent Application: Compound to direct molecular entities to the intracellular domain of neoplastic cells, active pharmaceutical ingredient comprising the aforementioned compound, pharmaceutical composition, method for diagnosis, prognosis and/or Cancer treatment. Patent number: BR1020180740377, INPI 22/11/2018. Depositor: Instituto Butantan. Inventors: Chudzinski-Tavassi, A.M.; Alvarez-Flores, M.P.; Morais, K.L.P.; Mourier, G.; Servent, D.

Patent Application “Anti-inflammatory peptides, pharmaceutical composition comprising such peptides and their uses”. Patent number: BR 10 2019 018666 6, INPI - Instituto Nacional da Propriedade Industrial. Data of deposit: 09/09/2019. Depositor: Instituto Butantan. Inventors: Chudzinski-Tavassi, A.M.; Alvarez-Flores, M.P.; Cury, Y.; Bufalo, M.C.; Kerkis, I.; Cerqueira, F.M.; Frare, E.O.